Palisade Bio, Inc. Share Price
PALIPalisade Bio, Inc. Stock Performance
Open $1.96 | Prev. Close $2.00 | Circuit Range N/A |
Day Range $1.91 - $2.00 | Year Range $0.53 - $2.61 | Volume 1,92,008 |
Average Traded $1.97 |
Palisade Bio, Inc. Share Price Chart
About Palisade Bio, Inc.
Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases. The company's lead therapeutic candidate is PALI-2108, a prodrug PDE4 inhibitor that is in phase 1a/b clinical trial for the treatment of ulcerative colitis, as well as under phase 1a clinical trial for the treatment of fibrostenotic crohn's disease. It has a research collaboration and license agreement with Giiant Pharma, Inc. for the development, manufacture, and commercialization of its compounds; a license agreement with the Regents of the University of California for sole purpose of maintaining the Newsoara Co-Development; and a co-development and distribution agreement with Newsoara Biopharma Co., Ltd. The company is headquartered in Carlsbad, California.
Palisade Bio, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
17-Mar-26 | $1.99 | $2.00 | -0.50% |
16-Mar-26 | $1.96 | $2.00 | +2.30% |
13-Mar-26 | $2.00 | $1.96 | -4.16% |
12-Mar-26 | $1.99 | $2.04 | +1.79% |
11-Mar-26 | $1.89 | $2.01 | +4.64% |
10-Mar-26 | $1.76 | $1.92 | +11.30% |
09-Mar-26 | $1.65 | $1.73 | +6.15% |
FAQs on Palisade Bio, Inc. Share Price
Can I buy Palisade Bio, Inc. shares in India?
What is the share price of Palisade Bio, Inc.?
What is the 5 year returns of Palisade Bio, Inc.?
What are the high & low stock price of Palisade Bio, Inc. today?
What is the 52-week high and low of Palisade Bio, Inc. stock?